Literature DB >> 10397417

Self-report and objective measures of cognitive deficit in patients entering substance abuse treatment.

M D Horner1, R T Harvey, C A Denier.   

Abstract

The relationship between self-reported cognitive deficits and objectively measured cognitive performance was examined in 86 patients entering substance abuse treatment. Self-ratings of cognitive impairment were strongly correlated with indices of depression and vulnerability to stress, but not with objective cognitive performance. Confirming the lack of relationship between self-report and objective cognitive measures, cognitive performance did not differ between patients at the extremes of the cognitive-complaint distribution; and cognitively impaired patients did not differ from cognitively intact patients in their self-ratings of impairment.

Entities:  

Mesh：

Year:  1999        PMID： 10397417     DOI： 10.1016/s0165-1781(99)00031-1

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN： 0165-1781            Impact factor:   3.222


  13 in total

Review 1.  Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse.

Authors:  Antonio Verdejo-García; Francisca López-Torrecillas; Carmen Orozco Giménez; Miguel Pérez-García
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

2.  Alcohol use biomarkers predicting cognitive performance: a secondary analysis in veterans with alcohol dependence and posttraumatic stress disorder.

Authors:  Raj K Kalapatapu; Kevin L Delucchi; Brooke A Lasher; Sophia Vinogradov; Steven L Batki
Journal:  Mil Med       Date:  2013-09       Impact factor: 1.437

3.  Relationships Between Cognitive Complaints and Quality of Life in Older Adults With Mild Cognitive Impairment, Mild Alzheimer Disease Dementia, and Normal Cognition.

Authors:  Shana D Stites; Kristin Harkins; Jonathan D Rubright; Jason Karlawish
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Oct-Dec       Impact factor: 2.703

4.  Association of alcohol use biomarkers and cognitive performance in veterans with problematic alcohol use and posttraumatic stress disorder: data from the mind your heart study.

Authors:  Raj K Kalapatapu; Thomas C Neylan; Mathilda C Regan; Beth E Cohen
Journal:  J Addict Dis       Date:  2014

5.  Cognition, commitment language, and behavioral change among cocaine-dependent patients.

Authors:  Efrat Aharonovich; Paul C Amrhein; Adam Bisaga; Edward V Nunes; Deborah S Hasin
Journal:  Psychol Addict Behav       Date:  2008-12

6.  Development of a patient-centred, patient-reported outcome measure (PROM) for post-stroke cognitive rehabilitation: qualitative interviews with stroke survivors to inform design and content.

Authors:  Emma L Patchick; Maria Horne; Kate Woodward-Nutt; Andy Vail; Audrey Bowen
Journal:  Health Expect       Date:  2014-12-05       Impact factor: 3.377

7.  Validity of cognitive complaints in substance-abusing patients and non-clinical controls: the Patient's Assessment of Own Functioning Inventory (PAOFI).

Authors:  Randall Richardson-Vejlgaard; Sharron Dawes; Robert K Heaton; Morris D Bell
Journal:  Psychiatry Res       Date:  2009-07-19       Impact factor: 3.222

8.  Relationship of age to impulsivity and decision making: a baseline secondary analysis of a behavioral treatment study in stimulant use disorders.

Authors:  Raj K Kalapatapu; Daniel F Lewis; Sophia Vinogradov; Steven L Batki; Theresa Winhusen
Journal:  J Addict Dis       Date:  2013

9.  Self-reported attention and mood symptoms in cocaine abusers: relationship to neurocognitive performance.

Authors:  Elysia S Benedict; Ashley Gorman; Wilfred van Gorp; Richard W Foltin; Nehal P Vadhan
Journal:  Psychiatry Res       Date:  2014-06-14       Impact factor: 3.222

10.  Rapid cognitive screening of patients with substance use disorders.

Authors:  Marc L Copersino; William Fals-Stewart; Garrett Fitzmaurice; David J Schretlen; Jody Sokoloff; Roger D Weiss
Journal:  Exp Clin Psychopharmacol       Date:  2009-10       Impact factor: 3.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.